Evidence map›Paper›PMID 26997225›Full record

ArticleThe Journal of biological chemistry2016

Staphylococcal Nuclease and Tudor Domain Containing 1 (SND1 Protein) Promotes Hepatocarcinogenesis by Inhibiting Monoglyceride Lipase (MGLL).

Devaraja Rajasekaran, Nidhi Jariwala, Rachel G Mendoza, Chadia L Robertson, Maaged A Akiel, Mikhail Dozmorov, Paul B Fisher, Devanand Sarkar

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
4.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 46 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Insights IntoFrontiers in oncology · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Devaraja RajasekaranFrom the Departments of Human and Molecular Genetics and.
Nidhi JariwalaFrom the Departments of Human and Molecular Genetics and.
Rachel G MendozaFrom the Departments of Human and Molecular Genetics and.
Chadia L RobertsonFrom the Departments of Human and Molecular Genetics and.
Maaged A AkielFrom the Departments of Human and Molecular Genetics and.
Mikhail DozmorovBiostatistics.
Paul B FisherFrom the Departments of Human and Molecular Genetics and Massey Cancer Center, and VCU Institute of Molecular Medicine, Virginia Commonwealth University, Richmond, Virginia 23298.
Devanand SarkarFrom the Departments of Human and Molecular Genetics and Massey Cancer Center, and VCU Institute of Molecular Medicine, Virginia Commonwealth University, Richmond, Virginia 23298 devanand.sarkar@vcuhealth.org.
Virginia Commonwealth University · USCancer Research And Biostatistics · US

Funding

Training Grant in Digestive Diseases and Liver DiseasesT32DK007150 · NIDDK · VIRGINIA COMMONWEALTH UNIVERSITY · PI SANYAL, ARUN J · 1986 to 2017
$4.2M
Analysis of a novel regulator of hepatocellular carcinomaR01CA138540 · NCI · VIRGINIA COMMONWEALTH UNIVERSITY · PI SARKAR, DEVANAND · 2010 to 2014
$1.6M
AEG-1: Novel Gene Involved in Malignant GliomaR01CA134721 · NCI · VIRGINIA COMMONWEALTH UNIVERSITY · PI FISHER, PAUL B · 2009 to 2013
$1.5M
A novel mediator of obesity associated hepatocellular carcinoma (HCC)R21CA183954 · NCI · VIRGINIA COMMONWEALTH UNIVERSITY · PI SARKAR, DEVANAND · 2014 to 2015
$365k
NCI NIH HHS R01 CA134721NCI NIH HHS R01 CA138540NCI NIH HHS R21 CA183954NIDDK NIH HHS T32 DK007150
6 · The paper itself

Abstract

Staphylococcal nuclease and tudor domain containing 1 (SND1) is overexpressed in multiple cancers, including hepatocellular carcinoma (HCC), and functions as an oncogene. This study was carried out to identify novel SND1-interacting proteins to better understand its molecular mechanism of action. SND1-interacting proteins were identified by a modified yeast two-hybrid assay. Protein-protein interaction was confirmed by co-immunoprecipitation analysis. Monoglyceride lipase (MGLL) expression was analyzed by quantitative RT-PCR, Western blot, and immunohistochemistry. MGLL-overexpressing clones were analyzed for cell proliferation and cell cycle analysis and in vivo tumorigenesis in nude mice. MGLL was identified as an SND1-interacting protein. Interaction of SND1 with MGLL resulted in ubiquitination and proteosomal degradation of MGLL. MGLL expression was detected in normal human hepatocytes and mouse liver, although it was undetected in human HCC cell lines. An inverse correlation between SND1 and MGLL levels was identified in a human HCC tissue microarray as well as in the TCGA database. Forced overexpression of MGLL in human HCC cells resulted in marked inhibition in cell proliferation with a significant delay in cell cycle progression and a marked decrease in tumor growth in nude mouse xenograft assays. MGLL overexpression inhibited Akt activation that is independent of enzymatic activity of MGLL and overexpression of a constitutively active Akt rescued cells from inhibition of proliferation and restored normal cell cycle progression. This study unravels a novel mechanism of SND1 function and identifies MGLL as a unique tumor suppressor for HCC. MGLL might function as a homeostatic regulator of Akt restraining its activation.

Indexed as

Cell CycleProteolysisAnimalsCarcinoma, HepatocellularCell Line, TumorCell Transformation, NeoplasticEndonucleasesGene Expression Regulation, EnzymologicGene Expression Regulation, NeoplasticHumansLiver NeoplasmsMiceMice, NudeMonoacylglycerol LipasesNuclear ProteinsProto-Oncogene Proteins c-aktEndonucleasesMonoacylglycerol LipasesNuclear ProteinsProto-Oncogene Proteins c-aktSND1 protein, humanTumor Suppressor ProteinsAkt PKBcell proliferationliver cancerMGLLprotein-protein interactionSND1tumor suppressor gene

Identifiers

PMID26997225
PMCPMC4865920
OpenAlexW2318304207

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.